15448007

Source:http://linkedlifedata.com/resource/pubmed/id/15448007

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0006142, umls-concept:C0030705, umls-concept:C0205225, umls-concept:C0220901, umls-concept:C1366459, umls-concept:C1522609, umls-concept:C1554112
pubmed:issue	18 Pt 1
pubmed:dateCreated	2004-9-27
pubmed:abstractText	BCAR1, the human homologue of the rat p130Cas protein, was identified in a functional screen for human breast cancer cell proliferation resistant to antiestrogen drugs. Here, we study the prognostic value of quantitative BCAR1 levels in a large series of breast cancer specimens.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9502500
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/BCAR1 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Crk-Associated Substrate Protein, http://linkedlifedata.com/resource/pubmed/chemical/Plasminogen Activator Inhibitor 1, http://linkedlifedata.com/resource/pubmed/chemical/Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Retinoblastoma-Like Protein p130, http://linkedlifedata.com/resource/pubmed/chemical/Urokinase-Type Plasminogen Activator
pubmed:status	MEDLINE
pubmed:month	Sep
pubmed:issn	1078-0432
pubmed:author	pubmed-author:BrinkmanArendA, pubmed-author:DorssersLambert C JLC, pubmed-author:FoekensJohn AJA, pubmed-author:Geurts-MoespotAnnekeA, pubmed-author:GrebenchtchikovNicolaiN, pubmed-author:KlijnJan G MJG, pubmed-author:LookMaxime PMP, pubmed-author:Meijer-van GelderMarion EME, pubmed-author:PetersHarry AHA, pubmed-author:PortengenHenkH, pubmed-author:SpanPaul NPN, pubmed-author:SweepFred C G JFC, pubmed-author:de JongDanielleD, pubmed-author:van BroekhovenSimone P JSP, pubmed-author:van TienovenDoorlene T HDT
pubmed:issnType	Print
pubmed:day	15
pubmed:volume	10
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	6194-202
pubmed:dateRevised	2008-11-21
pubmed:meshHeading	pubmed-meshheading:15448007-Adult, pubmed-meshheading:15448007-Aged, pubmed-meshheading:15448007-Breast Neoplasms, pubmed-meshheading:15448007-Cell Line, Tumor, pubmed-meshheading:15448007-Cell Proliferation, pubmed-meshheading:15448007-Chemotherapy, Adjuvant, pubmed-meshheading:15448007-Crk-Associated Substrate Protein, pubmed-meshheading:15448007-Cytosol, pubmed-meshheading:15448007-Disease-Free Survival, pubmed-meshheading:15448007-Enzyme-Linked Immunosorbent Assay, pubmed-meshheading:15448007-Female, pubmed-meshheading:15448007-Humans, pubmed-meshheading:15448007-Likelihood Functions, pubmed-meshheading:15448007-Middle Aged, pubmed-meshheading:15448007-Multivariate Analysis, pubmed-meshheading:15448007-Plasminogen Activator Inhibitor 1, pubmed-meshheading:15448007-Prognosis, pubmed-meshheading:15448007-Proportional Hazards Models, pubmed-meshheading:15448007-Proteins, pubmed-meshheading:15448007-Recurrence, pubmed-meshheading:15448007-Retinoblastoma-Like Protein p130, pubmed-meshheading:15448007-Urokinase-Type Plasminogen Activator
pubmed:year	2004
pubmed:articleTitle	The prognostic value of BCAR1 in patients with primary breast cancer.
pubmed:affiliation	Department of Pathology, Division of Molecular Biology, Erasmus MC Rotterdam, Rotterdam. l.dorssers@erasmusmc.nl
pubmed:publicationType	Journal Article, Research Support, Non-U.S. Gov't